The Business Research Company’s 2026 market reports are designed to deliver research that is more actionable and strategically valuable. Key offerings include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Bioprocess Technology Market Size, Growth Rate And Key Forecast Highlights For 2026–2030
The bioprocess technology market has experienced rapid expansion in recent years. Its market size is projected to grow from $28.71 billion in 2025 to $33.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.5%. The historical growth of this market can be attributed to several factors, including the expansion of biopharmaceutical manufacturing, the increasing adoption of cell-based therapies, the rise in research and development activities, the growing demand for biologics, and the availability of advanced laboratory infrastructure.
The bioprocess technology market size is projected to experience swift growth in the upcoming years. It is expected to expand to $59.03 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 15.5%. The expansion foreseen in the forecast period can be linked to increasing investments in biologics and biosimilars, the rising adoption of continuous bioprocessing, the expansion of personalized medicine production, a growing focus on sustainable biomanufacturing, and the increasing integration of digital process control systems. Major developments anticipated during this period include the increasing adoption of single-use bioprocessing systems, a rising demand for scalable cell culture technologies, growing integration of automation in bioreactors, the expansion of advanced cell line development techniques, and an enhanced focus on process optimization and yield efficiency.
See What’s Inside The Bioprocess Technology Market Report With A Free Sample:
Bioprocess Technology Market Expansion: The Major Factor Driving Growth
The bioprocess technology market’s growth is anticipated to be driven by the rising prevalence of chronic diseases. A chronic disease is defined as an illness persisting for three months or longer, with the potential to worsen over time. This technology is instrumental in advancing the medical field and enhancing individuals’ quality of life through its application in the development and production of gene therapies, vaccines, cell culture and fermentation processes, and monoclonal antibodies for chronic diseases. For example, data from January 2023, provided by the US-based National Library of Medicine, indicates that the population in the US aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million individuals, by 2050. Thus, the expanding occurrence of chronic diseases serves as a key driver for the bioprocess technology market’s expansion.
Understanding Bioprocess Technology Market Segmentation For Strategic Planning
The bioprocess technology market covered in this report is segmented –
1) By Type: Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Filtration
2) By Application: Biopharmaceuticals, Specialty Products, Industry Chemicals, Environment Management Aid
3) By End User: Hospitals, Research labs, Medical Institutions, Other End Users
Subsegments:
1) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
2) By Cell Expansion: Adherent Cell Expansion, Suspension Cell Expansion
3) By Flow Cytometry: Cell Analysis, Cell Sorting
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
5) By Virus Filtration: Viral Vector Production, Virus Filtration Techniques
Key Bioprocess Technology Market Trends To Watch In 2026
Companies active within the bioprocess technology market are developing innovative service options, such as the custom organoid line expansion service, to achieve a competitive advantage. This service employs proprietary bioreactor and bioprocess technology to facilitate the scaled-up production of organoids. For example, in July 2023, Molecular Devices LLC, a US-based Research and development company, introduced its custom organoid line expansion service. This offering assists researchers in screening thousands to tens of thousands of drug candidates concurrently on organoids derived from a single source. It aims to bolster next-generation drug discovery research and foster the creation of more efficient, reproducible, and scalable patient-derived organoids (PDOs).
Key Companies Active In The Bioprocess Technology Market
Major companies operating in the bioprocess technology market are Sartorius AG; Thermo Fisher Scientific Inc.; Lonza Group AG; F. Hoffmann-La Roche Ltd.; Becton Dickinson and Company; Merck KGa; GE Healthcare; Eppendorf AG; Bio-Rad Laboratories; Catalent Inc.; Advanced Instruments LLC; MilliporeSigma; Repligen Corporation; Danaher Corporation; PerkinElmer Inc.; Applikon Biotechnology; New Brunswick Scientific Co. Inc.; Avid Bioservices; Meissner Filtration Products; 3M; Eppendorf Biochip Systems; Fermenter Bioreactor; Solaris Biotechnology Srl; Aber Instruments; Cytiva
Explore Detailed Bioprocess Technology Market Research And Forecasts:
Which Geography Dominates The Bioprocess Technology Market?
North America was the largest region in the bioprocess technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioprocess technology market report during the forecast period. The regions covered in the bioprocess technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
